Hefei Lifeon Pharmaceutical Co., Ltd. (SHE:003020)
China
· Delayed Price · Currency is CNY 22.89
+0.29 (1.28%)
At close: Apr 29, 2026
SHE:003020 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 4,353 | 4,922 | 3,456 | 4,495 | 3,956 | 4,248 | Upgrade
|
| Market Cap Growth | 20.94% | 42.42% | -23.11% | 13.63% | -6.89% | 33.39% | Upgrade
|
| Enterprise Value | 4,106 | 4,651 | 3,230 | 4,180 | 3,310 | 3,631 | Upgrade
|
| Last Close Price | 22.89 | 25.88 | 17.50 | 22.33 | 19.51 | 20.95 | Upgrade
|
| PE Ratio | 26.31 | 29.80 | 21.52 | 19.83 | 18.90 | 24.67 | Upgrade
|
| Forward PE | - | 24.47 | 15.83 | 17.14 | - | - | Upgrade
|
| PS Ratio | 2.80 | 3.17 | 2.28 | 2.37 | 1.53 | 1.87 | Upgrade
|
| PB Ratio | 2.23 | 2.52 | 1.81 | 2.40 | 2.67 | 3.26 | Upgrade
|
| P/TBV Ratio | 2.66 | 3.01 | 2.22 | 3.00 | 2.83 | 3.50 | Upgrade
|
| P/FCF Ratio | 46.10 | 52.12 | 80.29 | 732.38 | - | - | Upgrade
|
| P/OCF Ratio | 20.45 | 23.12 | 17.50 | 22.07 | 19.72 | 26.77 | Upgrade
|
| EV/Sales Ratio | 2.64 | 2.99 | 2.13 | 2.20 | 1.28 | 1.60 | Upgrade
|
| EV/EBITDA Ratio | 15.74 | 18.54 | 14.24 | 17.31 | 14.99 | 18.17 | Upgrade
|
| EV/EBIT Ratio | 24.69 | 27.97 | 21.26 | 20.31 | 16.99 | 21.07 | Upgrade
|
| EV/FCF Ratio | 43.48 | 49.26 | 75.04 | 681.13 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.03 | 0.03 | 0.06 | 0.05 | 0.01 | 0.02 | Upgrade
|
| Debt / EBITDA Ratio | 0.24 | 0.24 | 0.50 | 0.35 | 0.06 | 0.12 | Upgrade
|
| Debt / FCF Ratio | 0.68 | 0.68 | 2.76 | 14.41 | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.20 | -0.20 | -0.20 | -0.25 | -0.42 | -0.48 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.55 | -1.55 | -1.72 | -1.97 | -2.85 | -3.15 | Upgrade
|
| Net Debt / FCF Ratio | -4.13 | -4.13 | -9.05 | -77.56 | 13.74 | 22.30 | Upgrade
|
| Asset Turnover | 0.60 | 0.60 | 0.60 | 0.83 | 1.36 | 1.42 | Upgrade
|
| Inventory Turnover | 2.59 | 2.59 | 2.07 | 3.08 | 5.88 | 7.16 | Upgrade
|
| Quick Ratio | 1.82 | 1.82 | 1.60 | 1.62 | 1.61 | 2.98 | Upgrade
|
| Current Ratio | 2.26 | 2.26 | 2.04 | 2.12 | 2.33 | 3.72 | Upgrade
|
| Return on Equity (ROE) | 8.46% | 8.46% | 8.05% | 13.95% | 15.03% | 13.90% | Upgrade
|
| Return on Assets (ROA) | 4.02% | 4.02% | 3.75% | 5.59% | 6.41% | 6.71% | Upgrade
|
| Return on Invested Capital (ROIC) | 9.68% | 9.70% | 9.23% | 16.64% | 22.29% | 27.55% | Upgrade
|
| Return on Capital Employed (ROCE) | 8.10% | 8.10% | 7.60% | 10.60% | 13.00% | 12.80% | Upgrade
|
| Earnings Yield | 3.79% | 3.36% | 4.65% | 5.04% | 5.29% | 4.05% | Upgrade
|
| FCF Yield | 2.17% | 1.92% | 1.25% | 0.14% | -1.16% | -0.66% | Upgrade
|
| Dividend Yield | 2.21% | - | 2.86% | 1.87% | 1.64% | 1.65% | Upgrade
|
| Payout Ratio | 100.59% | 100.59% | 50.40% | 27.03% | 30.99% | 26.90% | Upgrade
|
| Buyback Yield / Dilution | 0.68% | 0.68% | 0.47% | -1.75% | -0.49% | -33.01% | Upgrade
|
| Total Shareholder Return | 2.90% | 0.68% | 3.33% | 0.12% | 1.15% | -31.37% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.